GE HealthCare Technologies (GEHC) is a Top-Ranked Value Stock: Should You Buy?

Group 1 - Zacks Premium offers various tools for investors, including daily updates on Zacks Rank and Industry Rank, access to the Zacks 1 Rank List, Equity Research reports, and Premium stock screens [1][2] - The Zacks Style Scores rate stocks based on value, growth, and momentum characteristics, helping investors identify securities with high potential to outperform the market [2][3] Group 2 - Each stock receives a rating from A to F based on its value, growth, and momentum, with A being the highest score indicating a better chance of outperforming [3] - The Value Score identifies attractive and discounted stocks using ratios like P/E, PEG, and Price/Sales [3][4] - The Growth Score focuses on a company's financial strength and future outlook, analyzing projected and historical earnings, sales, and cash flow [4] - The Momentum Score helps investors capitalize on price trends, using factors like one-week price change and monthly earnings estimate changes [5] Group 3 - The VGM Score combines all Style Scores, providing a comprehensive indicator for investors who utilize multiple investing styles [6] - The Zacks Rank employs earnings estimate revisions to simplify portfolio building, with 1 (Strong Buy) stocks achieving an average annual return of +25.41% since 1988, significantly outperforming the S&P 500 [7][8] Group 4 - Investors are encouraged to select stocks with Zacks Rank 1 or 2 and Style Scores of A or B to maximize returns [10] - Stocks with lower ranks, such as 4 (Sell) or 5 (Strong Sell), even with high Style Scores, may still face downward price trends [11] Group 5 - GE HealthCare Technologies Inc. is a leading provider of medical technology and digital solutions, formed on January 3, 2023, after a spin-off from General Electric [12] - GE HealthCare has a Zacks Rank of 3 (Hold) and a VGM Score of B, with a Value Style Score of B due to a forward P/E ratio of 19.39 [12][13] - The company has seen upward revisions in earnings estimates, with the Zacks Consensus Estimate increasing by $0.01 to $4.70 per share, and an average earnings surprise of 6.2% [13]